Pluvicto supplies

Active Awarded Last action

Contract number
36C25526N0394
Awardee
Awarding agency
Obligated
$891,651

Award facts

Contract value 100% obligated
$891,650.76 Current and potential, with all options
Completion date 48% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
St. Louis, MO 63106, USA

Award details come from SAM.gov/FPDS.

About this award

Veterans Integrated Service Network 15 issued a delivery order to Novartis Pharmaceuticals Corporation on August 5, 2026, for PLUVICTO (Lutetium Lu-177 Vipivotide Tetra), a radiopharmaceutical for metastatic castration-resistant prostate cancer, with a ceiling value of $891,650.76 and an ultimate completion date of February 5, 2027. The order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).

Place of performance is St. Louis, MO 63106. No set-aside was used. The order carries firm fixed price pricing.

Quick answers

Who was awarded contract 36C25526N0394?

36C25526N0394 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 15 (Veterans Health Administration) on August 5, 2026.

How much is contract 36C25526N0394 worth?

The government has obligated $891,651 on 36C25526N0394.

Is contract 36C25526N0394 an order under another contract?

Yes. 36C25526N0394 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25526N0394 competed?

The extent of competition for 36C25526N0394 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award